PD-L1 expression in ROS1-rearranged non-small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1.
Jongmin LeeChan Kwon ParkHyoung-Kyu YoonYoung Jo SaIn Sook WooHyo Rim KimSue Youn KimTae-Jung KimPublished in: Thoracic cancer (2018)
In the largest consecutive routine Asian NSCLC cohort analyzed to date, we found that high PD-L1 expression frequently overlapped with ROS1 rearrangement, while it negatively correlated with EGFR mutations.